WO2019009326A1 - 樹脂製シリンジ、プレフィルドシリンジ、および樹脂製シリンジの製造方法 - Google Patents
樹脂製シリンジ、プレフィルドシリンジ、および樹脂製シリンジの製造方法 Download PDFInfo
- Publication number
- WO2019009326A1 WO2019009326A1 PCT/JP2018/025353 JP2018025353W WO2019009326A1 WO 2019009326 A1 WO2019009326 A1 WO 2019009326A1 JP 2018025353 W JP2018025353 W JP 2018025353W WO 2019009326 A1 WO2019009326 A1 WO 2019009326A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- syringe
- resin
- printing layer
- syringe body
- ink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/0427—Coating with only one layer of a composition containing a polymer binder
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/03—Printing inks characterised by features other than the chemical nature of the binder
- C09D11/033—Printing inks characterised by features other than the chemical nature of the binder characterised by the solvent
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/10—Printing inks based on artificial resins
- C09D11/106—Printing inks based on artificial resins containing macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
- A61L2/07—Steam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2323/00—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
- C08J2323/02—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers not modified by chemical after treatment
- C08J2323/10—Homopolymers or copolymers of propene
- C08J2323/12—Polypropene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2345/00—Characterised by the use of homopolymers or copolymers of compounds having no unsaturated aliphatic radicals in side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic or in a heterocyclic ring system; Derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2423/00—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
- C08J2423/02—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers not modified by chemical after treatment
- C08J2423/10—Homopolymers or copolymers of propene
- C08J2423/12—Polypropene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2423/00—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
- C08J2423/26—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers modified by chemical after-treatment
- C08J2423/28—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers modified by chemical after-treatment by reaction with halogens or halogen-containing compounds
Definitions
- the present invention relates to a resin syringe, a prefilled syringe, and a method of manufacturing a resin syringe.
- the prefillable syringe is a syringe for producing a prefilled syringe filled with a drug, and there are one made of glass and one made of resin.
- Resin-made syringes have attracted attention in recent years as pre-fillable syringes because they are lighter than glass-made syringes, do not break when dropped, and have good dimensional accuracy.
- Resin syringes are made of cyclic olefin polymers, polyolefins such as polypropylene to ensure transparency, but since these resins do not have polar groups, the scale for displaying the volume of the drug, drug name, use It is not suitable to print and display the deadline, logo, lot number etc. directly.
- this invention makes it a subject to provide the manufacturing method of resin-made syringes, prefilled syringes, and resin-made syringes in which printing layers, such as a scale printed on the outer surface of a syringe main body, do not separate easily.
- the present inventors diligently studied to solve the above problems.
- it is a resin-made syringe provided with the syringe main body made from polyolefin, and the printing layer printed on at least one part of the outer surface of the said syringe main body, Comprising:
- the said printing layer is chlorination rate 15-30 %,
- the outer surface on which the printing layer is printed has a plurality of recesses, and the plurality of recesses each have a diameter of 50 nm or more and less than 1 ⁇ m.
- the manufacturing method of resin-made syringes, prefilled syringes, and resin-made syringes which the printing layer printed on the syringe main body does not peel easily can be provided.
- Example 1 It is a TEM image (5000 times of magnification) of Example 1 which constitutes an example of an experiment of the present invention.
- 1 is a TEM image (magnification of 10000 times) of Example 1.
- FIG. It is a TEM image (magnification 5000 times) of comparative example 1.
- 1 is a TEM image of Example 1 (2000 ⁇ magnification).
- 7 is a TEM image of Comparative Example 1 (2000 ⁇ magnification).
- X to Y indicating a range means “X or more and Y or less”. Unless otherwise specified, measurements of operations and physical properties etc. are conducted under the conditions of room temperature (20 to 25 ° C.) / Relative humidity 40 to 50% RH.
- [Resin syringe] 1 to 4 are diagrams for explaining the prefilled syringe 1 or the resin syringe 10 according to an embodiment of the present invention.
- the prefilled syringe 1 according to the embodiment of the present invention can be outlined with reference to FIG. 1.
- the resin syringe 10 provided with the syringe main body 11, the medicine filled in the storage space 16 of the syringe main body 11, and the syringe main body 11 And a gasket 30 slidably disposed in the accommodation space 16 of the syringe body 11, and a plunger 40.
- a prefilled syringe may be called a cartridge, when it is incorporated and used for the administration tool for administering the medicine with which the syringe body was filled.
- the resin-made syringe 10 includes a syringe body 11 made of polyolefin and a printing layer 18 printed on at least a part of the outer surface 17 of the syringe body 11 , And the resin-made syringe 10 is provided.
- the printing layer 18 has a component including chlorinated polypropylene having a chlorination rate of 15 to 30%, a colorant and a filler as shown in FIG. 4, and the outer surface 17 on which the printing layer 18 is printed has a plurality of recesses. It has nineteen.
- Each of the plurality of recesses 19 has a depth d1 of 50 nm or more and less than 1 ⁇ m, and a width d2 of 50 nm or more and less than 1 ⁇ m.
- Each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18.
- the resin-made syringe 10 includes a syringe body 11 provided with a nozzle portion 13 for discharging a liquid such as a drug to the outside, and a printing layer 18 provided on the outer surface of the syringe body 11.
- the printing layer 18 is a scale indicating the internal volume of the syringe body 11.
- some loaded drugs may require close control of drug dosage.
- the label when displaying a scale line with a label, the label itself deviates about ⁇ 1 mm from the position where the scale line was aimed, and the drug dose could not be strictly controlled.
- the printing layer 18 is formed directly on the outer surface 17 of the syringe body 11, the deviation from the position where the scale line is aimed deviates within ⁇ 0.1 mm. Can be significantly reduced. For this reason, it is suitable for the syringe which must control a medicine dose strictly.
- the printing layer 18 may display the drug name, the expiration date, the logo, the lot number, the stop target position of the gasket 30, the backward allowable position, and the like.
- the syringe main body 11 is, as shown in FIG. 3, a flange 12 provided at the proximal end of the syringe main body 11, a nozzle portion 13 provided at the distal end of the syringe main body 11, and a housing formed inside the syringe main body 11. And a space 16.
- the syringe body 11 is formed in a hollow cylindrical shape as an example.
- the flange 12 is formed to project radially outward from the outer surface of the proximal end portion of the syringe body 11.
- the nozzle portion 13 is provided to protrude in the distal direction.
- the nozzle unit 13 includes a discharge unit 14 that discharges a liquid such as a drug, and an attachment unit 15 provided so as to surround the outer peripheral surface of the discharge unit 14.
- the nozzle portion 13 is formed as a double cylindrical shape as shown in FIG. 3, and the inner cylindrical portion corresponds to the discharge portion 14 and the outer cylindrical portion corresponds to the attachment portion 15.
- the tip of the discharge part 14 is open and constitutes the tip opening of the syringe body 11.
- the attaching portion 15 is a portion to which another medical instrument such as a non-illustrated injection needle is attached, and is integrally configured with the syringe body 11 in the present embodiment. As shown in FIG. 3, on the inner wall surface of the mounting portion 15, a female screw portion that is screwed with the male screw portion of the mounting portion of another medical device such as an injection needle is provided.
- the attachment portion 15 can also be configured as a separate part from the other portions of the syringe body 11. Moreover, the attaching part 15 may be abbreviate
- the housing space 16 corresponds to a portion of a cylindrically shaped radially inward cavity of the syringe body 11. By filling a medicine or the like in the storage space 16 and inserting a gasket, the prefilled syringe 1 can be obtained.
- the housing space 16 is formed along substantially the entire syringe body 11 along the axial direction of the syringe body 11.
- the cap 20 includes a substantially cylindrical grip portion 21 and a sealing portion 22 that seals the distal end opening of the syringe main body 11.
- the cap 20 is attached to the syringe body 11 by fitting the sealing portion 22 to the outer peripheral surface of the nozzle portion 13 of the syringe body 11.
- the gripping portion 21 is disposed on the tip end side of the mounting portion 15 of the nozzle portion 13 and is a portion gripped by the user when removing the cap 20 from the syringe main body 11.
- the syringe body and the sealing member may be configured differently from the configurations shown in FIGS. 1 to 3. Specifically, instead of the nozzle portion 13 of the syringe main body 11, a hollow puncture needle fixed to the tip of the syringe main body 11 is provided. Then, instead of the cap 20 attached to the nozzle portion 13, a sealing member may be used which is attached to the tip of the syringe body to cover the puncture needle and seal the tip opening of the puncture needle. In this case, the distal end opening of the puncture needle constitutes the distal end opening of the syringe body, and the distal end of the puncture needle is pierced into the sealing member, whereby the distal end opening of the puncture needle is sealed.
- a sealing member fixed non-removably to the nozzle portion of the syringe body may be used instead of the cap 20, a sealing member fixed non-removably to the nozzle portion of the syringe body may be used.
- the sealing member is punctured by the medical instrument with a needle, whereby the accommodation space and the outside communicate with each other.
- the syringe body 11 of the present invention is made of polyolefin. Therefore, it has a technical effect that it is light, does not break when dropped, and has good dimensional accuracy as compared to a glass syringe.
- the polyolefin constituting the syringe body 11 is a cycloolefin polymer (COP), a cycloolefin copolymer (COC) or a polypropylene (PP).
- COP cycloolefin polymer
- COC cycloolefin copolymer
- PP polypropylene
- cycloolefin polymer a polymer obtained by ring-opening polymerization of a ring-opening polymerizable cycloolefin-based monomer such as norbornenes or cyclotetradodecenes and hydrogenation is preferably used.
- a cycloolefin copolymer the copolymer (addition copolymer of a norbornene-type monomer and an alpha-olefin) which uses olefins, such as norbornene and ethylene, as a raw material, tetracyclododecenes, ethylene, etc.
- the copolymer which uses the olefins of 5 as a raw material is used suitably.
- a cycloolefin polymer COP
- Zeonex resin ZEONEX
- COC cycloolefin copolymer
- APEL resin manufactured by Mitsui Chemicals, Inc.
- the resin-made syringe 10 of embodiment of this invention is equipped with the syringe main body 11 made of polyolefin, and the printing layer 18 printed on at least one part of the outer surface 17 of the syringe main body 11 as shown in FIG.
- the printing layer 18 has a component including chlorinated polypropylene having a chlorination rate of 15 to 30%, a colorant and a filler as shown in FIG. 4, and the outer surface 17 on which the printing layer 18 is printed has a plurality of recesses. It has nineteen.
- Each of the plurality of recesses 19 has a depth d1 of 50 nm or more and less than 1 ⁇ m, and a width d2 of 50 nm or more and less than 1 ⁇ m.
- Each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18.
- the plurality of recesses 19 in the outer surface 17 on which the printing layer 18 is printed is only from those with a depth d1 and a width d2 of 50 nm or more and less than 1 ⁇ m as shown in FIG. Become. Further, according to one embodiment of the present invention, the plurality of recesses 19 each have a depth d1 of 50 to 200 nm and a width d2 of 100 to 500 nm. With this embodiment, the anchor effect between the print layer 18 and the outer surface 17 can be enhanced while enhancing the mechanical strength of the syringe body 11.
- the outer surface 17 of the syringe body 11 itself is usually smooth without having a portion considered as a recess 19.
- the outer surface 17 on which the printing layer 18 is printed has a recess 19 deeper than the outer surface 17 of the near region adjacent to the outer surface 17.
- the near region is an arbitrary region on the outer surface 17 of the syringe main body 11 adjacent to the print layer 18 where the print layer 18 is not printed.
- At least one of the components of the printing layer 18 filling each of the plurality of recesses 19 is a chlorinated polyolefin.
- the anchor effect is further enhanced by the fact that the chlorinated polyolefin having good adhesion to the polyolefin which is the syringe body 11 (base material) enters the recess 19.
- the printing layer 18 has an adjacent lamella structure of chlorinated polypropylene adjacent to the outer surface 17 of the syringe body 11. And in the cross section along the axis of the syringe body 11, the sum of the axial length of the adjacent lamellar structure of chlorinated polypropylene is 10% or less of the axial length d5 of the printing layer 18 shown in FIG. According to this embodiment, since the lamellar structure of chlorinated polypropylene which weakens the adhesive strength between the outer surface 17 of the syringe main body 11 and the printing layer 18 exists only in a very limited range, the outer surface 17 of the syringe main body 11 And the adhesive strength of the printing layer 18 can be enhanced.
- the print layer 18 may have a lamellar structure of chlorinated polypropylene at a position separated from the outer surface 17 of the syringe main body 11 separately from the adjacent lamellar structure.
- the printing layer 18 has a body region spaced from the outer edge of the printing layer 18 in the direction along the outer surface 17 of the syringe body 11 by at least 3 ⁇ m (see length d3 in FIG. 4)
- the thickness d4 of the print layer 18 in the main body region is 1 to 10 ⁇ m. By being in such a range, it can be said that the ink is printed at the targeted position, and the display accuracy is improved.
- the thickness of the printing layer 18 in the main body region is more preferably 2 to 8 ⁇ m.
- the outer surface 17 on which the print layer 18 is printed and the print layer 18 are not compatible. Since the outer surface 17 on which the printing layer 18 is printed and the printing layer 18 are not compatible with each other, the properties and physical properties of the material of the syringe body 11 are not changed. For this reason, a substance derived from the material of the syringe main body 11 which has been changed due to compatibility dissolves into the drug in the syringe main body 11, the strength of the syringe main body 11 decreases, and the syringe main body 11 is easily broken or high pressure Unable to withstand steam sterilization is suppressed. Thus, according to one embodiment of the present invention, the outer surface 17 on which the print layer 18 is printed and the print layer 18 have a clear interface.
- the printing layer 18 is formed by applying the ink to the outer surface 17 of the polyolefin syringe body 11.
- the ink has a component including a volatile solvent containing a dissolving component for dissolving the polyolefin, a chlorinated polypropylene having a chlorination ratio of 15 to 30%, a colorant and a filler.
- Such inks are also referred to herein as inks of the present invention (or simply "inks").
- the ink of the present invention comprises chlorinated polypropylene.
- the chlorination rate of chlorinated polypropylene is 15 to 30%.
- the chlorination rate is preferably 20 to 29%, more preferably 23 to 28%, and preferably 25 to 27%.
- the chlorination ratio is 8.3 to 3.6% with respect to H in a propylene unit [—CH (CH 3 ) —CH 2 —] in chlorinated polypropylene. With such a range, it is possible to form the print layer 18 that is more difficult to peel off.
- chlorinated polypropylene is contained in the ink preferably in an amount of 10 to 35% by mass, more preferably 13 to 30% by mass, and still more preferably 16 to 30% by mass. With such a range, it is possible to form the print layer 18 that is more difficult to peel off.
- the chlorinated polypropylene which can be used in the present invention may be synthesized with reference to a conventionally known method, or may be prepared by purchasing a commercially available product.
- the ink of the present invention contains a colorant.
- the color of the colorant is not particularly limited, but a black ink is often used for the printing layer.
- a black coloring agent which can be used for the ink of the present invention for example, carbon black such as furnace black, channel black, acetylene black, thermal black, lamp black and the like, and further magnetic powder such as magnetite and ferrite are preferable.
- colorants of other colors known colorants that can be used in the art can be applied.
- the colorant is preferably contained in the ink in an amount of 3 to 15% by mass, more preferably 5 to 10% by mass. With such a range, it is possible to form the printing layer 18 that is difficult to peel off and easy to view.
- the ink of the present invention contains a filler.
- the filler By including the filler, the dispersibility of the ink can be improved and the gloss can be controlled.
- the type of the filler is not particularly limited, but, for example, barium sulfate, talc, calcium carbonate, zinc carbonate, wollastonite, silica, alumina, magnesium oxide, calcium silicate, sodium aluminate, calcium aluminate, sodium aluminosilicate, silica Magnesium, zinc oxide, antimony trioxide, zeolite, hydrotalcite, metal fiber, metal whisker, ceramic whisker, potassium titanate, boron nitride, inorganic filler such as carbon fiber, starch, cellulose fine particle, natural origin such as wood powder You may make it contain organic fillers, such as a polymer and these modified products.
- barium sulfate can function as an extender pigment and can also function as a stabilizer to prevent the dehydrochlorination reaction of
- the filler is contained in the ink preferably in an amount of 15 to 60% by mass, more preferably 25 to 45% by mass, and still more preferably 25 to 35% by mass. By being in such a range, it is possible to form the print layer 18 which is difficult to peel off and has less color unevenness.
- the ink of the present invention comprises a volatile solvent containing a dissolving component for dissolving the polyolefin.
- chlorinated polypropylene can be efficiently dissolved in a volatile solvent.
- solubility of chlorinated polypropylene can be improved more by combining toluene and trimethylbenzene.
- Trimethylbenzene is at least one of 1,2,4-trimethylbenzene, 1,2,3-trimethylbenzene and 1,3,5-trimethylbenzene.
- the volatile solvent comprises a dissolving component for dissolving the polyolefin.
- the dissolution component is an aromatic hydrocarbon having a benzene ring structure and a side chain of hydrocarbon, and the carbon number of the side chain of the hydrocarbon is 2 or more.
- the carbon number is preferably 2 to 10, and more preferably 2 to 5.
- the volatile solvent is contained in the ink preferably in an amount of 15 to 40% by mass, more preferably 20 to 35% by mass, and still more preferably 20 to 30% by mass (two types When the above volatile solvents are included, it is the total amount).
- the ink preferably contains 15 to 40% by mass, and more preferably 20 to 30% by mass of toluene.
- the printing layer 18 preferably contains 14 to 50% by weight of chlorinated polypropylene having a rate of 15 to 30%, and preferably 18 to 43% by weight of chlorinated polypropylene. More preferably, it comprises ⁇ 30% chlorinated polypropylene. Also, according to one embodiment of the present invention, the printing layer 18 preferably contains 4 to 22% by mass of the colorant, and more preferably 7 to 14% by mass of the colorant. Also, according to one embodiment of the present invention, the printing layer 18 preferably contains 21 to 86% by weight of filler, and more preferably 35 to 64% by weight of filler.
- the outer surface 17 of the syringe body 11 is sterilized by an autoclave.
- the recess 19 of the syringe body 11 is filled with at least one of the components of the printing layer 18, it is technically that peeling of the printing layer 18 is suppressed even when autoclave sterilization is performed. effective.
- the method of an autoclave is mentioned later.
- the resin syringe 10 is a syringe before being filled with a drug.
- the prefilled syringe 1 can be obtained by providing the cap 20 for sealing the tip opening of the syringe body 11 and the gasket 30 slidably disposed in the accommodation space 16 of the syringe body 11 . Therefore, the prefilled syringe 1 slides in the syringe 10 made of resin, the medicine filled in the syringe body 11 of the syringe 10 made of resin, the cap 20 for sealing the tip opening of the syringe body 11, and the syringe body 11 And a gasket 30 which is arranged as possible.
- Such a prefilled syringe 1 does not use a label and does not peel off the label, and the drug dose can be strictly controlled.
- the drug is filled in the syringe body 11 in a larger amount than the dose
- the printing layer 18 is a position where the internal volume of the syringe body 11 matches the dose of the drug. Is a scale printed on. Since the print layer 18 is formed directly on the outer surface 17 of the syringe body 11, the deviation of the scale from the intended position is very small. For this reason, when advancing the gasket to the graduations in order to adjust the amount of drug in the syringe body 11 to the dose, the amount of drug in the syringe body 11 can be reliably adjusted to the dose. In particular, in the case of a small dose of a dose of 0.5 mL or less, the amount of drug in the syringe body 11 when advancing the gasket to the scale line is more reliably adjusted to the dose. Accuracy is extremely important.
- FIG. 5 is a flowchart showing a method of manufacturing a resin-made syringe according to an embodiment of the present invention.
- a syringe body 11 made of polyolefin is prepared.
- an ink is prepared having a volatile solvent containing a dissolving component for dissolving the polyolefin, a chlorinated polypropylene having a chlorination ratio of 15 to 30%, a colorant and a component including a filler (preparation step (ST1)).
- the ink is applied to at least a part of the outer surface 17 of the syringe body 11 (application step (ST2)).
- the applied ink is dried to form a print layer 18 having components including the chlorinated polypropylene, the colorant, and the filler on the outer surface 17 (drying step (ST3)).
- a plurality of recesses 19 are formed on the outer surface 17 by dissolving at least a part of the outer surface 17 with the dissolving component, and each of the plurality of recesses 19 is at least one of the components of the ink Fill with Then, by drying the ink, each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18.
- the syringe body 11 made of polyolefin is prepared. Furthermore, there is a preparation step of preparing an ink having a component including a volatile solvent containing a dissolving component for dissolving the polyolefin, a chlorinated polypropylene having a chlorination ratio of 15 to 30%, a colorant and a filler (FIG. 5) See ST1).
- the syringe body 11 made of polyolefin can be prepared by purchasing a commercially available one as described above.
- the ink can be prepared by appropriately mixing the components constituting the ink described above.
- the method for producing a resin-made syringe of the present invention has an applying step of applying the ink to at least a part of the outer surface 17 of the syringe main body 11 (see ST2 in FIG. 5).
- the method for producing a resin-made syringe of the present invention has a drying step of forming a printing layer 18 having a component containing the colorant and the filler (see ST3 in FIG. 5).
- the application step may apply an amount sufficient to print the print layer 18, and the application amount can be appropriately set according to the print area of the print layer 18.
- the printing layer 18 is a scale indicating the internal volume of the syringe body 11, it is preferable to apply the ink so as to form a linear scale line along the circumferential direction of the syringe body 11.
- the thickness of the scale line is preferably 0.1 to 1.0 mm, and more preferably 0.3 to 0.6 mm. Only one scale line may be provided on the outer surface 17 of the syringe body 11 as a scale line indicating the dose of the drug. Further, a plurality of scale lines may be intermittently provided to indicate a plurality of internal volumes of the syringe body 11.
- coating in a coating process For example, it is suitable to use screen printing, offset printing, etc.
- drying conditions in the drying step are not particularly limited as long as the volatile solvent in the ink is substantially volatilized.
- a plurality of recesses 19 are formed on the outer surface 17 by dissolving at least a part of the outer surface 17 with the dissolving component. Each is filled with at least one of the components of the ink. Then, by drying the ink, each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18. In this manner, as shown in FIGS. 2 to 4, the resin-made syringe 10 in which the printing layer 18 is printed on at least a part of the outer surface 17 of the syringe body 11 made of polyolefin can be produced.
- the printing layer 18 contains a component including chlorinated polypropylene having a chlorination rate of 15 to 30%, a colorant, and a filler.
- the outer surface 17 on which the printing layer 18 is printed has a plurality of recesses 19.
- Each of the plurality of recesses 19 has a depth d1 of 50 nm or more and less than 1 ⁇ m, and a width d2 of 50 nm or more and less than 1 ⁇ m.
- Each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18.
- a method of manufacturing the resin syringe 10 is provided.
- a syringe body 11 made of polyolefin is prepared, and an ink having a component including a volatile solvent containing a dissolving component for dissolving the polyolefin, a chlorinated polypropylene having a chlorination ratio of 15 to 30%, a colorant and a filler prepare.
- the ink is applied to the outer surface 17 of the syringe body 11.
- the applied ink is dried to form a print layer 18 having components including chlorinated polypropylene, a colorant and a filler on the outer surface 17.
- a plurality of concave portions 19 are formed on the outer surface 17 by dissolving at least a part of the outer surface 17 with the dissolving component. Then, each of the plurality of recesses 19 is filled with at least one of the components of the ink. In the drying of the ink, each of the plurality of recesses 19 is filled with at least one of the components of the printing layer 18 by volatilizing the volatile solvent in the ink component.
- an empty syringe for drug loading such as a pre-fillable syringe, must be kept clean and sterile until the drug loading, so that sterilization is carried out in the packaging material in advance. Can be applied. Therefore, according to one embodiment of the present invention, it has a sterilization process (refer to ST4 of Drawing 5) which carries out autoclave sterilization of syringe body 11.
- autoclave sterilization is preferably performed at 121-125 ° C., more preferably at 121-123 ° C. Also, according to one embodiment of the present invention, autoclave sterilization is preferably performed for 20 to 120 minutes, more preferably for 20 to 90 minutes, still more preferably for 20 to 60 minutes.
- Example 1 The ink is formed on one portion of the outer surface 17 of the syringe body 11 of the cycloolefin polymer (ZEONEX (registered trademark) Nippon Zeon Co., Ltd.) so as to form an annular continuous linear scale in the circumferential direction of the syringe body 11 It applied.
- the ink prepared by the following method was applied using a curved surface screen printer (SK-250-S type) manufactured by Shinei Kogyo Co., Ltd. while rotating the syringe main body 11 around the axis. Then, by drying at 60 ° C. for 30 minutes, a resin-made syringe 10 having a reference line indicating the dose of the drug was produced.
- Comparative Example 1 A resin syringe 10 was produced in the same manner as in Example 1 except that the ink was prepared as follows.
- the outer surface of the syringe section was observed in a bright field using a transmission electron microscope (TEM) (magnification of 5000, 10000).
- TEM transmission electron microscope
- the observed TEM images are shown in FIG. 6 (Example 1: 5000 times), FIG. 7 (Example 1: 10000 times), FIG. 8 (Comparative Example 1: 5000 times) and FIG. 9 (Comparative Example 1: 10000 times).
- the white particles of about several hundreds of nm or so observed in the print layer 18 are barium sulfate, and the aggregate of gray particles of about 30 to 50 nm observed in the print layer 18 is carbon black. .
- FIG. 10 and FIG. 11 are TEM images of a magnification of 2000 ⁇ taken in the same manner as described above of Example 1 and Comparative Example 1, respectively.
- the thickness d4 of the print layer 18 in the portion separated from the outer edge 18a of the print layer 18 by 3 ⁇ m was 1.5 ⁇ m.
- the thickness d4 of the printing layer 18 is less than 1 ⁇ m even in the portion 3 ⁇ m away from the end of the printing layer 18 (in FIG. 11, the end is further on the lower left).
- peeling test The peeling test was conducted with reference to JIS K5600-5-6: 1999 (I2409: 1992). Specifically, Sellotape (registered trademark) CT-18 was strongly crimped along the axis of the syringe body so as to straddle the print portion, and the end of the tape was pulled off at a stretch of 60 °. As a result, in Example 1, clear peeling was not visually recognized, and in Comparative Example 1, it was visually recognized that some peeling was performed.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Epidemiology (AREA)
Abstract
Description
図1~4は、本発明の一実施形態に係るプレフィルドシリンジ1又は樹脂製シリンジ10の説明に供する図である。本発明の実施形態に係るプレフィルドシリンジ1は、図1を参照して概説すれば、シリンジ本体11を備える樹脂製シリンジ10と、シリンジ本体11の収容空間16に充填された薬剤と、シリンジ本体11の先端開口を封止するキャップ20(封止部材に相当)と、シリンジ本体11の収容空間16に摺動可能に配置されたガスケット30と、プランジャ40と、を備える。なお、プレフィルドシリンジは、シリンジ本体に充填された薬剤を投与するための投与具に組み込まれて使用される場合、カートリッジと呼ばれることもある。
本発明のシリンジ本体11は、ポリオレフィン製である。ゆえに、ガラス製シリンジと比べて、軽く、落としても割れず、また寸法精度もよい技術的効果を有する。
本発明の実施形態の樹脂製シリンジ10は、図2に示すようにポリオレフィン製のシリンジ本体11と、シリンジ本体11の外表面17の少なくとも一部に印刷された印刷層18と、を備える。印刷層18は、図4に示すように塩素化率15~30%の塩素化ポリプロピレン、着色剤およびフィラーを含む成分を有し、印刷層18が印刷されている外表面17は、複数の凹部19を有する。複数の凹部19はそれぞれ、50nm以上、1μm未満の深さd1と、50nm以上、1μm未満の幅d2とを有する。複数の凹部19はそれぞれ、印刷層18の成分のうちの少なくとも1種で満たされている。かかる構成を有することによって、印刷層18と、外表面17との間にアンカー効果が生じ、接着強度が向上する。
本発明のインクは、塩素化ポリプロピレンを含む。そして、塩素化ポリプロピレンの塩素化率は15~30%である。本発明の一実施形態において、塩素化率は20~29%であることが好ましく、23~28%であることがより好ましく、25~27%であることが好ましい。かような範囲であることによって、本発明の所期の効果を効率的に奏することができる。また、本発明の一実施形態において、塩素化ポリプロピレンにおけるプロピレンユニット[-CH(CH3)-CH2-]中のHに対して8.3~3.6%の塩素化率である。かような範囲であることによって、より剥離し難い印刷層18を形成することができる。
本発明のインクは、着色剤を含む。着色剤の色には特に制限はないが、印刷層には、黒色のインクが用いられることが多い。本発明のインクに用いられうる黒色の着色剤としては、たとえば、ファーネスブラック、チャンネルブラック、アセチレンブラック、サーマルブラック、ランプブラック等のカーボンブラック、更にマグネタイト、フェライト等の磁性粉等が好適である。その他の色の着色剤は、当該分野で使用可能な公知の着色剤が適用可能である。
本発明のインクは、フィラーを含む。フィラーを含むことによってインクの分散性が向上し、光沢性を制御することができる。フィラーの種類も特に制限はないが、例えば、硫酸バリウム、タルク、炭酸カルシウム、炭酸亜鉛、ワラストナイト、シリカ、アルミナ、酸化マグネシウム、珪酸カルシウム、アルミン酸ナトリウム、アルミン酸カルシウム、アルミノ珪酸ナトリウム、珪酸マグネシウム、酸化亜鉛、三酸化アンチモン、ゼオライト、ハイドロタルサイト、金属繊維、金属ウィスカー、セラミックウィスカー、チタン酸カリウム、窒化ホウ素、炭素繊維等の無機フィラーや澱粉、セルロース微粒子、木粉等の天然由来のポリマーやこれらの変性品等の有機フィラーを含有させてもよい。特に硫酸バリウムは、体質顔料として機能し得、また、塩素化ポリプロピレンの脱塩化水素化反応を防止するための安定剤としても機能し得る。
本発明のインクは、前記ポリオレフィンを溶解する溶解成分を含有する揮発性溶媒を含む。
次に本実施形態に係る樹脂製シリンジ10の製造方法について説明する。図5は、本発明の一実施形態に係る樹脂製シリンジの製造方法について示すフローチャートである。当該方法では、図5に示すようにポリオレフィン製のシリンジ本体11を準備する。さらに、前記ポリオレフィンを溶解する溶解成分を含有する揮発性溶媒、塩素化率15~30%の塩素化ポリプロピレン、着色剤およびフィラーを含む成分を有するインクを準備する(準備工程(ST1))。次に、シリンジ本体11の外表面17の少なくとも一部に、前記インクを塗布する(塗布工程(ST2))。次に、塗布されたインクを乾燥させて、外表面17に、前記塩素化ポリプロピレン、前記着色剤および前記フィラーを含む成分を有する、印刷層18を形成する(乾燥工程(ST3))。塗布工程では、前記溶解成分で外表面17の少なくとも一部を溶解することにより外表面17に複数の凹部19を形成するとともに、複数の凹部19のそれぞれを前記インクの成分のうちの少なくとも1種で満たす。そして、前記インクの乾燥により、複数の凹部19のそれぞれを印刷層18の成分のうちの少なくとも1種で満たす。
本発明の樹脂製シリンジ10の製造方法では、ポリオレフィン製のシリンジ本体11を準備する。さらに、前記ポリオレフィンを溶解する溶解成分を含有する揮発性溶媒、塩素化率15~30%の塩素化ポリプロピレン、着色剤およびフィラーを含む成分を有するインクを準備する、準備工程を有する(図5のST1参照)。
本発明の樹脂製シリンジの製造方法は、シリンジ本体11の外表面17の少なくとも一部に、前記インクを塗布する、塗布工程を有する(図5のST2参照)。また、本発明の樹脂製シリンジの製造方法は、前記着色剤および前記フィラーを含む成分を有する、印刷層18を形成する、乾燥工程を有する(図5のST3参照)。
本発明の一実施形態において、プレフィラブルシリンジのような薬剤充填用の空のシリンジは、薬剤充填時まで清浄な無菌状態にしておかねばならないため、予め包材内に収納した状態で滅菌処理が施されうる。よって、本発明の一実施形態によれば、シリンジ本体11をオートクレーブ滅菌する、滅菌工程(図5のST4参照)を有する。
シクロオレフィンポリマー(ゼオネックス(登録商標) 日本ゼオン株式会社製)のシリンジ本体11の外表面17の一カ所に、シリンジ本体11の周方向に環状に連続した線状の目盛線となるようにインクを塗布した。具体的には、シリンジ本体11を軸周りに回転させながら、以下の方法で調製したインクを新栄工業社製の曲面用スクリーン印刷機(SK-250-S型)を用いて塗布した。その後、60℃、30分で乾燥することによって、薬剤の投与量を示す標線を有する樹脂製シリンジ10を作製した。
トルエン 26部と、
トリメチルベンゼン 6.5部と、
ナフタレン2部と、
カーボンブラック 8部と、
塩素化率26%の塩素化ポリプロピレン 20部(東洋紡社製のハードレン(登録商標)(13-LLP))と、
p-シメン0.5部と、
硫酸バリウム 37部と、
を含む成分を有するインクを、各成分を混合することによって調製した。
インクの調製を以下のようにした以外は、実施例1と同様にして樹脂製シリンジ10を作製した。
トルエン 29部と、
トリメチルベンゼン 6.5部と、
ナフタレン1.5部と、
メタノール 2部と、
イソブタノール 0.5部と、
カーボンブラック 8部と、
塩素化率22~25%の塩素化ポリエチレン(昭和電工社製のエラスレン(登録商標)(グレード:252B)) 20部と、
硫酸バリウム 32.5部と、
を含む成分を有するインクを、各成分を混合することによって調製した。
(界面の観察)
実施例1および比較例1で作製された、印刷層18が印刷されている、樹脂製シリンジ10をそれぞれ、白金コートした後、Luft法で樹脂包埋した。その後、シリンジ本体11の軸に沿って超薄切片(シリンジ切片)を作製した。
実施例1のシリンジ切片の元素分布を、エネルギー分散型X線分光法を用いて、観察した。その結果、塩素はシリンジ本体に観察されなかった。塩素は塩素化ポリプロピレン由来のものであるため、つまり、印刷層18が印刷されている外表面17と、印刷層18とは、相溶していないことが示唆される。換言すれば、印刷層18が印刷されている外表面17と、印刷層18とには明瞭な界面が形成されていることが言える。
実施例1のシリンジ切片において無作為に選択した10個の箇所で撮影して得られた画像中で明確に凹部19と認識できたもの全てについて、その最大幅と最大深度とをスケールバーを参照して測定した。その結果、実施例1における凹部19の深さd1と、幅d2(図4参照)とは、それぞれ、50~150nm、50~200nmの範囲にあった。
図10および図11は、それぞれ実施例1および比較例1の、上記と同様に撮影した倍率2000倍のTEM画像である。図4、10において、実施例1では、印刷層18の外縁18aから3μm(図4の長さd3参照)離間した部分の印刷層18の厚みd4が、1.5μmであった。また、図11において、比較例1では、印刷層18の端部(図11では、端部がさらに左下の方に存在する)から3μm離間した部分でも、印刷層18の厚みd4は、1μm未満であった。
JIS K5600-5-6:1999(I2409:1992)を参考に剥離試験を行った。具体的には、セロテープ(登録商標)CT-18をシリンジ本体の軸に沿って印刷部分を跨ぐようにして強く圧着させ、テープの端を60°の角度で一気に引き剥がした。その結果、実施例1では、明確な剥離は視認されず、比較例1では、一部剥離したことが視認された。
10 樹脂製シリンジ、
11 シリンジ本体、
17 外表面、
18 印刷層、
20 キャップ(封止部材)、
30 ガスケット、
40 プランジャ、
d1 (凹部の)深さ、
d2 (凹部の)幅、
d3 (印刷層の軸方向における外縁からの)長さ、
d4 (印刷層の外縁から長さd3離間した位置での)厚み、
d5 (印刷層の)軸方向長。
Claims (15)
- ポリオレフィン製のシリンジ本体と、前記シリンジ本体の外表面の少なくとも一部に印刷された印刷層と、を備えた、樹脂製シリンジであって、
前記印刷層が、塩素化率15~30%の塩素化ポリプロピレン、着色剤およびフィラーを含む成分を有し、
前記印刷層が印刷されている前記外表面は、複数の凹部を有し、
前記複数の凹部はそれぞれ、50nm以上、1μm未満の深さと、50nm以上、1μm未満の幅とを有し、かつ、前記印刷層の成分のうちの少なくとも1種で満たされている、樹脂製シリンジ。 - 前記複数の凹部のそれぞれを満たしている前記印刷層の成分のうちの前記少なくとも1種が、塩素化ポリオレフィンである、請求項1に記載の樹脂製シリンジ。
- 前記ポリオレフィンが、シクロオレフィンポリマー、シクロオレフィンコポリマーまたはポリプロピレンである、請求項1または2に記載の樹脂製シリンジ。
- 前記複数の凹部はそれぞれ、50~200nmの深さと、100~500nmの幅とを有する、請求項1~3のいずれか1項に記載の樹脂製シリンジ。
- 前記印刷層が、前記シリンジ本体の前記外表面に隣接した塩素化ポリプロピレンの隣接ラメラ構造を有し、前記シリンジ本体の軸に沿った断面において、塩素化ポリプロピレンの隣接ラメラ構造の軸方向長の合計は、前記印刷層の軸方向長の10%以下となっている、請求項1~4のいずれか1項に記載の樹脂製シリンジ。
- 前記印刷層が、前記シリンジ本体の前記外表面に沿う方向における前記印刷層の外縁から3μm以上離間した本体領域を有し、前記本体領域における前記印刷層の厚みは、1~10μmである、請求項1~5のいずれか1項に記載の樹脂製シリンジ。
- 前記印刷層が印刷されている前記外表面と、前記印刷層とは、相溶していない、請求項1~6のいずれか1項に記載の樹脂製シリンジ。
- 前記印刷層が、前記シリンジ本体の内容量を示す目盛線である、請求項1~7のいずれか1項に記載の樹脂製シリンジ。
- オートクレーブ滅菌済である、請求項1~8のいずれか1項に記載の樹脂製シリンジ。
- 請求項1~9のいずれか1項に記載の樹脂製シリンジと、
前記樹脂製シリンジのシリンジ本体内に充填された薬剤と、
前記シリンジ本体の先端開口を封止する封止部材と、
前記シリンジ本体内に摺動可能に配置されたガスケットと、を備えたプレフィルドシリンジ。 - 前記薬剤は、前記シリンジ本体内に投与量よりも多く充填されており、
前記印刷層は、前記シリンジ本体の内容量が前記薬剤の前記投与量と一致する位置に印刷された目盛線である請求項10に記載のプレフィルドシリンジ。 - 樹脂製シリンジの製造方法であって、
ポリオレフィン製のシリンジ本体を準備し、さらに、前記ポリオレフィンを溶解する溶解成分を含有する揮発性溶媒、塩素化率15~30%の塩素化ポリプロピレン、着色剤およびフィラーを含む成分を有するインクを準備する、準備工程と;
前記シリンジ本体の外表面の少なくとも一部に、前記インクを塗布する、塗布工程と;
塗布された前記インクを乾燥させて、前記外表面に、前記塩素化ポリプロピレン、前記着色剤および前記フィラーを含む成分を有する、印刷層を形成する、乾燥工程と;を有し、
前記塗布工程において、前記溶解成分で前記外表面の少なくとも一部を溶解することにより前記外表面に複数の凹部を形成するとともに、前記複数の凹部のそれぞれを前記インクの成分のうちの少なくとも1種で満たし、前記インクの乾燥により、前記複数の凹部のそれぞれを前記印刷層の成分のうちの少なくとも1種で満たすことを有する、樹脂製シリンジの製造方法。 - 前記溶解成分が、ベンゼン環構造と炭化水素の側鎖とを有する芳香族炭化水素であって、前記炭化水素の側鎖の炭素数が2以上である、請求項12に記載の樹脂製シリンジの製造方法。
- 前記インクが、トルエンを15~40質量%含む、請求項12または13に記載の樹脂製シリンジの製造方法。
- 前記シリンジ本体をオートクレーブ滅菌する、滅菌工程を有する、請求項12~14のいずれか1項に記載の樹脂製シリンジの製造方法。
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019527742A JP7051850B2 (ja) | 2017-07-04 | 2018-07-04 | 樹脂製シリンジ、プレフィルドシリンジ、および樹脂製シリンジの製造方法 |
| EP18827619.0A EP3650063B1 (en) | 2017-07-04 | 2018-07-04 | Syringe formed from resin, pre-filled syringe, and method for producing syringe formed from resin |
| CN201880044543.XA CN110831644A (zh) | 2017-07-04 | 2018-07-04 | 树脂制注射器、预灌封注射器、以及树脂制注射器的制造方法 |
| AU2018295781A AU2018295781B2 (en) | 2017-07-04 | 2018-07-04 | Resin-made syringe, prefilled syringe, and method for producing resin-made syringe |
| CN202511007841.XA CN120771389A (zh) | 2017-07-04 | 2018-07-04 | 树脂制注射器、预灌封注射器、以及树脂制注射器的制造方法 |
| US16/734,089 US20200139051A1 (en) | 2017-07-04 | 2020-01-03 | Resin syringe, prefilled syringe, and method for producing resin syringe |
| JP2022057062A JP7291828B2 (ja) | 2017-07-04 | 2022-03-30 | 樹脂製シリンジ、プレフィルドシリンジ、および樹脂製シリンジの製造方法 |
| US18/115,706 US12383679B2 (en) | 2017-07-04 | 2023-02-28 | Resin syringe, prefilled syringe, and method for producing resin syringe |
| US18/198,193 US11975178B2 (en) | 2017-07-04 | 2023-05-16 | Resin syringe, prefilled syringe, and method for producing resin syringe |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017131526 | 2017-07-04 | ||
| JP2017-131526 | 2017-07-04 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/734,089 Continuation US20200139051A1 (en) | 2017-07-04 | 2020-01-03 | Resin syringe, prefilled syringe, and method for producing resin syringe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019009326A1 true WO2019009326A1 (ja) | 2019-01-10 |
Family
ID=64950102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2018/025353 Ceased WO2019009326A1 (ja) | 2017-07-04 | 2018-07-04 | 樹脂製シリンジ、プレフィルドシリンジ、および樹脂製シリンジの製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20200139051A1 (ja) |
| EP (1) | EP3650063B1 (ja) |
| JP (2) | JP7051850B2 (ja) |
| CN (2) | CN110831644A (ja) |
| AU (1) | AU2018295781B2 (ja) |
| WO (1) | WO2019009326A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2023073864A1 (ja) * | 2021-10-28 | 2023-05-04 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0217078A (ja) * | 1988-07-05 | 1990-01-22 | Top:Kk | 目盛付フッ素樹脂留置カテーテルとその製造方法 |
| JPH09314793A (ja) * | 1996-05-31 | 1997-12-09 | Dainippon Printing Co Ltd | 化粧シート |
| JP2006520639A (ja) * | 2003-03-20 | 2006-09-14 | コンセプチュアル テクノロジーズ インコーポレイティッド | 内容物を符号化した医療用注射器、注射器セット及び注射器内容物識別方法 |
| JP2007276346A (ja) * | 2006-04-10 | 2007-10-25 | Dainippon Printing Co Ltd | 印刷物の製造方法及びその方法で得られた化粧材 |
| JP2008272162A (ja) | 2007-04-27 | 2008-11-13 | Ajinomoto Co Inc | シリンジラベル及びシリンジ |
| JP2017131526A (ja) | 2016-01-29 | 2017-08-03 | 東芝ライフスタイル株式会社 | 自律走行式掃除機 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275729A (en) * | 1979-10-29 | 1981-06-30 | Jules Silver | Adjustable dosage syringe |
| JPS5867736A (ja) * | 1981-10-19 | 1983-04-22 | Showa Denko Kk | ポリオレフイン組成物 |
| US4724508A (en) * | 1985-12-18 | 1988-02-09 | Becton, Dickinson And Company | Method and apparatus for the continuous corona discharge treatment of the surface of formed articles |
| AU623730B2 (en) * | 1989-02-08 | 1992-05-21 | Becton Dickinson & Company | Syringe having graphic visualization features |
| JP2596884B2 (ja) * | 1993-04-27 | 1997-04-02 | 日本製紙株式会社 | 低温流動性が良好なバインダー樹脂溶液組成物 |
| CA2279737C (en) * | 1998-08-06 | 2004-04-27 | Naoya Haruta | Decorative film for use in platics molding, process for preparing the same and injection-molded part by use of the same |
| US6966897B2 (en) * | 2000-09-22 | 2005-11-22 | Arte Corporation | Combined container-syringe and assembly method of the same |
| WO2005068153A1 (en) * | 2004-01-07 | 2005-07-28 | Smiths Medical Asd, Inc. | Needle protection device with gauge specific color coding and method for manufacturing thereof |
| JP2006057056A (ja) * | 2004-08-23 | 2006-03-02 | Dainichiseika Color & Chem Mfg Co Ltd | ポリプロピレンフィルム用グラビアインキ |
| US20080188814A1 (en) * | 2007-01-22 | 2008-08-07 | Adi Lavi-Loebl | Syringe and syringe label |
| US8062254B2 (en) | 2008-01-08 | 2011-11-22 | MacLean, LLC | Spring driven adjustable oral syringe |
| CN201969136U (zh) * | 2011-01-26 | 2011-09-14 | 成都市新津事丰医疗器械有限公司 | 一次性使用注射器丝网外套 |
| JP6166564B2 (ja) * | 2013-03-22 | 2017-07-19 | 日本製紙株式会社 | 塩素化ポリオレフィン樹脂組成物 |
| JP6291318B2 (ja) * | 2014-03-31 | 2018-03-14 | テルモ株式会社 | ロクロニウム臭化物注射液充填プレフィルドシリンジ |
| WO2015173260A1 (en) * | 2014-05-12 | 2015-11-19 | Formycon Ag | Pre-filled plastic syringe containing a vegf antagonist |
| JP2016149193A (ja) * | 2015-02-10 | 2016-08-18 | 新興プラスチックス株式会社 | 導光板の製造方法及び当該方法によって製造された導光板 |
| CN105419090A (zh) * | 2015-12-14 | 2016-03-23 | 山东凯利医疗器械有限公司 | 一种一次性注射器用聚丙烯材料及其制备方法 |
| US10076881B2 (en) * | 2016-09-08 | 2018-09-18 | Xerox Corporation | System and method for forming a base layer with interfacial anchoring to stabilize a three-dimensional object during additive manufacturing |
| CN110191805A (zh) * | 2017-01-30 | 2019-08-30 | 优泊公司 | 热塑性树脂膜以及粘合标签 |
| AT521806A2 (de) | 2017-06-30 | 2020-05-15 | Ccl Secure Pty Ltd | Verfahren zum Herstellen von Mikrobildelementen auf einem Substrat |
-
2018
- 2018-07-04 JP JP2019527742A patent/JP7051850B2/ja active Active
- 2018-07-04 AU AU2018295781A patent/AU2018295781B2/en active Active
- 2018-07-04 CN CN201880044543.XA patent/CN110831644A/zh active Pending
- 2018-07-04 CN CN202511007841.XA patent/CN120771389A/zh active Pending
- 2018-07-04 EP EP18827619.0A patent/EP3650063B1/en active Active
- 2018-07-04 WO PCT/JP2018/025353 patent/WO2019009326A1/ja not_active Ceased
-
2020
- 2020-01-03 US US16/734,089 patent/US20200139051A1/en not_active Abandoned
-
2022
- 2022-03-30 JP JP2022057062A patent/JP7291828B2/ja active Active
-
2023
- 2023-02-28 US US18/115,706 patent/US12383679B2/en active Active
- 2023-05-16 US US18/198,193 patent/US11975178B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0217078A (ja) * | 1988-07-05 | 1990-01-22 | Top:Kk | 目盛付フッ素樹脂留置カテーテルとその製造方法 |
| JPH09314793A (ja) * | 1996-05-31 | 1997-12-09 | Dainippon Printing Co Ltd | 化粧シート |
| JP2006520639A (ja) * | 2003-03-20 | 2006-09-14 | コンセプチュアル テクノロジーズ インコーポレイティッド | 内容物を符号化した医療用注射器、注射器セット及び注射器内容物識別方法 |
| JP2007276346A (ja) * | 2006-04-10 | 2007-10-25 | Dainippon Printing Co Ltd | 印刷物の製造方法及びその方法で得られた化粧材 |
| JP2008272162A (ja) | 2007-04-27 | 2008-11-13 | Ajinomoto Co Inc | シリンジラベル及びシリンジ |
| JP2017131526A (ja) | 2016-01-29 | 2017-08-03 | 東芝ライフスタイル株式会社 | 自律走行式掃除機 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2023073864A1 (ja) * | 2021-10-28 | 2023-05-04 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3650063C0 (en) | 2024-01-24 |
| US20200139051A1 (en) | 2020-05-07 |
| US12383679B2 (en) | 2025-08-12 |
| US20230201465A1 (en) | 2023-06-29 |
| AU2018295781A1 (en) | 2020-01-23 |
| JPWO2019009326A1 (ja) | 2020-05-07 |
| CN110831644A (zh) | 2020-02-21 |
| AU2018295781B2 (en) | 2020-12-24 |
| JP2022082657A (ja) | 2022-06-02 |
| JP7051850B2 (ja) | 2022-04-11 |
| US20230285679A1 (en) | 2023-09-14 |
| CN120771389A (zh) | 2025-10-14 |
| JP7291828B2 (ja) | 2023-06-15 |
| EP3650063B1 (en) | 2024-01-24 |
| EP3650063A1 (en) | 2020-05-13 |
| US11975178B2 (en) | 2024-05-07 |
| EP3650063A4 (en) | 2020-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9839750B2 (en) | Syringe with visually coded needle hub | |
| EP2543405B1 (en) | Syringe | |
| JP6411097B2 (ja) | プレフィルドシリンジ | |
| DE602004008951T2 (de) | Niedrig extrahierbare thermoplastische spritze und endkappe | |
| US6663601B2 (en) | Sterilizable transfer or storage device for medicaments, drugs and vaccines | |
| US6981618B2 (en) | Container assembly for a substance to be applied | |
| CN103889705A (zh) | 涂覆制品的机械应力检测 | |
| JP2015512760A (ja) | コンポーネントの適切な結合を示すインジケータを持つ自己注射装置 | |
| US11975178B2 (en) | Resin syringe, prefilled syringe, and method for producing resin syringe | |
| JPWO2010122872A1 (ja) | 医療用容器およびシリンジ | |
| WO2012041946A1 (en) | Finger-grip device for medical syringe or cartridge | |
| WO2009107224A1 (ja) | プランジャロッド及び注射器 | |
| JP2011194045A (ja) | 薬剤投与具 | |
| WO2017188256A1 (ja) | シリンジ用バレル及びプレフィルドシリンジ | |
| JP5444835B2 (ja) | プレフィルドシリンジ用注射器およびプレフィルドシリンジ | |
| US20190231983A1 (en) | Colored Seal System, Method, and Apparatus | |
| JP2012000146A (ja) | シリンジ | |
| US10098812B2 (en) | Multi-component container | |
| JP4173302B2 (ja) | 医療用針 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18827619 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2019527742 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2018295781 Country of ref document: AU Date of ref document: 20180704 Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2018827619 Country of ref document: EP Effective date: 20200204 |